Management of infections in critically ill neutropenic cancer patients
Because of improving antineoplastic treatment options with increasing cure rates, prolonging survival, and improving quality of life, the reluctance to admit patients with malignant disease to an intensive care unit is not justified; thus, the number of patients with malignancies treated in intensiv...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 October 2004
|
| In: |
Journal of critical care
Year: 2004, Volume: 19, Issue: 3, Pages: 165-173 |
| ISSN: | 1557-8615 |
| DOI: | 10.1016/j.jcrc.2004.07.007 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jcrc.2004.07.007 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0883944104000528 
|
| Author Notes: | Dieter Buchheidt, Margit Hummel, Georg Engelich, and Rüdiger Hehlmann |
| Summary: | Because of improving antineoplastic treatment options with increasing cure rates, prolonging survival, and improving quality of life, the reluctance to admit patients with malignant disease to an intensive care unit is not justified; thus, the number of patients with malignancies treated in intensive care units rises. The use of more aggressive anticancer regimens leads to an increase of attendant infections, which are the most frequent and often life-threatening complications in cancer patients. A multidisciplinary practical approach to evaluation and treatment is needed to optimize treatment results and to meet the various diagnostic and therapeutic challenges in this subset of patients on an intensive care unit. |
|---|---|
| Item Description: | Gesehen am 13.05.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1557-8615 |
| DOI: | 10.1016/j.jcrc.2004.07.007 |